Non-invasive assessment of postoperative disease recurrence in Crohn's Disease: a multicenter, prospective cohort study on behalf of the IG-IBD.

Date publication

décembre 2022

Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Furfaro F, D'Amico F, Zilli A, Craviotto V, Aratari A, Bezzio C, Spinelli A, Gilardi D, Radice S, Saibeni S, Papi C, Peyrin-Biroulet L, Danese S, Fiorino G, Allocca M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36521739

Résumé

Colonoscopy (CS) is the gold standard to assess postoperative recurrence (POR) in Crohn's disease (CD). However, CS is invasive and may be poorly tolerated by patients. The aim of this study was to prospectively assess the diagnostic accuracy of a non-invasive approach in detecting POR, using the endoscopic Rutgeerts' score (RS) as the reference standard.

Mots clés

Crohn’s disease, bowel ultrasound, fecal calprotectin, non-invasive test, post-operative recurrence

Référence

Clin Gastroenterol Hepatol. 2022 12 12;: